Big technology companies show no signs of slowing their spending on artificial intelligence, even though a payoff still looks a long way away.
OpenAI and the FDA are reportedly discussing AI for drug evaluations
- today, 5:09 PM
- techcrunch.com
- 0

Big technology companies show no signs of slowing their spending on artificial intelligence, even though a payoff still looks a long way away.
No comments